Abstract
CTNNB1, encoding β-catenin and associated with regulation of WNT pathway, plays an important role in development of hepatocellular carcinoma (HCC). It was reported as an immune-resistant biomarker in HCC. However, the landscape of CTNNB1 mutations in Chinese HCC patients and mechanisms of CTNNB1 mutations underlying immune resistance remain unclear.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
